Mol. Cells 2019; 42(12): 828-835
Published online December 16, 2019
https://doi.org/10.14348/molcells.2019.0241
© The Korean Society for Molecular and Cellular Biology
Correspondence to : kwkim@hallym.ac.kr
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.
PIWI Argonaute proteins and Piwi-interacting RNAs (piRNAs) are expressed in all animal species and play a critical role in cellular defense by inhibiting the activation of transposable elements in the germline. Recently, new evidence suggests that PIWI proteins and piRNAs also play important roles in various somatic tissues, including neurons. This review summarizes the neuronal functions of the PIWI-piRNA pathway in multiple animal species, including their involvement in axon regeneration, behavior, memory formation, and transgenerational epigenetic inheritance of adaptive memory. This review also discusses the consequences of dysregulation of neuronal PIWI-piRNA pathways in certain neurological disorders, including neurodevelopmental and neurodegenerative diseases. A full understanding of neuronal PIWI-piRNA pathways will ultimately provide novel insights into small RNA biology and could potentially provide precise targets for therapeutic applications.
Keywords neurological disorders, non-coding RNA, posttranscriptional gene silencing, small RNA, transposable elements
PIWI-interacting RNAs (piRNAs) are small non-coding regulatory RNAs and fall into the same biological category as microRNAs (miRNAs) and small interfering RNAs (siRNAs) (Aravin et al., 2006; Girard et al., 2006). piRNAs form a complex with the PIWI protein and can be found in both vertebrates and invertebrates. piRNAs are distinct from miRNAs in several features, the first is size (piRNAs are generally 24 to 32 nucleotides in length rather than 21 nucleotides), second a lack of sequence conservation, and third independence from Dicer for biogenesis (Vagin et al., 2006; Weick and Miska, 2014). piRNAs often show a bias for a 5′ uridine (Brennecke et al., 2007; Ruby et al., 2006; Stein et al., 2019) and have 2′-O-methylation at the 3′-end (Horwich et al., 2007; Kirino and Mourelatos, 2007; Ohara et al., 2007; Peng et al., 2018; Saito et al., 2007; Tang et al., 2016) (Fig. 1). piRNA is the most diverse class of regulatory RNAs in general. According to piRBase, the number of unique piRNA sequences in the mouse is over 68 million; in
PIWI proteins belong to the Argonaute/Piwi family (Carmell et al., 2002). Like all Argonaute proteins, PIWI proteins contain two RNA-binding domains: the N-terminal PAZ domain and the C-terminal Piwi domain (Cerutti et al., 2000) (Fig. 2A). The Piwi domain has endonuclease activity that allows it to cleave RNA. The PIWI protein was initially described in
The PIWI-piRNA pathway relies on the specificity provided by the piRNA sequence which recognizes its RNA targets using base-pairing complementarity (Gou et al., 2014; Rouget et al., 2010; Saito et al., 2007; Shen et al., 2018; Zhang et al., 2018), while the PIWI protein functions as the effector (Tolia and Joshua-Tor, 2007). PIWI-piRNA complexes silence their target genes at both the transcriptional level and at the posttranscriptional level (Di Giacomo et al., 2013; Toth et al., 2016; Weick and Miska, 2014) (Fig. 1). Gene silencing at the transcriptional level often occurs through the recruitment of repressive chromatin modifications to genomic target loci (Ashe et al., 2012; Le Thomas et al., 2013; Shirayama et al., 2012; Sienski et al., 2012) and
Given that one of the major roles of the piRNA pathway is the inactivation of transposable elements, impairment of this pathway can lead to overexpression of transposable elements, which may result in increased genome stability and thus germ cell defects and sterility. However, many animals produce piRNAs that do not target transposon sequences. For example, the vast majority of piRNAs produced in
PIWI proteins and piRNAs have been identified in various somatic tissues including neural cells, although it should be noted that their expression levels are significantly lower in these tissues than in the germline. A number of studies have detected the expression of piRNAs in the mammalian brain (Dharap et al., 2011; Ghosheh et al., 2016; Lee et al., 2011a; Nandi et al., 2016; Perera et al., 2019; Phay et al., 2018). In mouse brain tissues researchers have identified approximately 30,000 neuronal piRNAs, and interestingly, these neuronal piRNAs are most like PIWIL2 (MIWI) associated piRNAs found in mouse testes (Ghosheh et al., 2016). These somatic piRNAs are shorter in length and tissue-specific, with increased occurrence of unique piRNAs in the hippocampus when compared to the germline (Perera et al., 2019). Hippocampal tissues showed the highest expression of piRNAs of any of the somatic tissues tested, followed by the brain cortex, kidney, and liver (Perera et al., 2019). These findings suggest that the role of neuronal piRNAs might be associated with neurogenesis and learning and memory.
Like other organisms,
Importantly, this inhibitory role in axon regeneration seems to be evolutionarily conserved as a reduction in a PIWI-like protein in cultured adult rat sensory neurons increases axonal regrowth after injury (Phay et al., 2018). In this study, PIWIL1 (MIWI) was detected in rat nervous tissue lysates, and its knockdown enhanced axon regrowth in cultured peripheral neurons after axonal injury. In addition, the authors also detected several neuronal piRNAs in rat sciatic nerve axoplasm and found that many of them are differentially expressed after nerve injury (e.g., piR-1199) (Phay et al., 2018). Another independent study in adult rat brains showed that numerous piRNAs are differentially expressed following transient focal ischemia in the rat cerebral cortex (Dharap et al., 2011).
Furthermore, PIWIL1 (MIWI) is expressed in the mouse Schwann cell and the expression was dramatically reduced following sciatic nerve injury (Sohn et al., 2019). Additionally, thousands of piRNAs were differentially expressed following nerve injury in this model, and one piRNA (piR 009614) even enhanced the migration of Schwann cells.
Together, these nematode and rodent studies suggest that the piRNA pathway may contribute to neuron or Schwann cell responses during peripheral nerve injury. Further studies should be done to determine the exact mechanisms behind PIWI and piRNA mediated axon regeneration and degeneration as well as to elucidate the specific piRNAs and their targets which regulate these neuronal responses after nerve injury.
Another likely role for PIWI and piRNAs in the neuron has been described in
In
Another recent study selectively disrupted PIWI proteins by simultaneous knockdown of two
Transgenerational epigenetic inheritance (TEI) refers to the phenomenon whereby epigenetic information is preserved in multiple generations even when the initiating environment or genetic event is no longer present (Boskovic and Rando, 2018). Environmental challenges, including high temperature (Casier et al., 2019b), starvation (Rechavi et al., 2014), and osmotic stress (Burton et al., 2017), can produce responses that are maintained across generations. In addition, researchers have shown that acquired memory events like traumatic stress (Gapp et al., 2014) and conditioned fear responses (Dias and Ressler, 2014) can also be inherited for up to two generations in mice.
Although the molecular and cellular mechanisms underlying TEI are largely unknown, several mechanisms have been identified as mediators of epigenetic inheritance, including DNA methylation, histone modification, and small RNAs (i.e., siRNAs and piRNAs) (Boskovic and Rando, 2018; Casier et al., 2019a). piRNAs have been shown to affect the epigenetic inheritance via the induction of paramutations in the heritable RNA interference (RNAi) pathway (Ashe et al., 2012; de Vanssay et al., 2012; Houri-Ze’evi et al., 2016; Sapetschnig et al., 2015; Shirayama et al., 2012). In the germline of
Strikingly,
Another groundbreaking discovery by Posner et al. (2019) provided insights into the small RNA-based mechanism of how the nervous system communicates with the germline to affect animal behavior transgenerationally. The authors first identified neuronal small RNAs and focused their research on the endo-siRNAs produced in an RDE-4 (
Transposable elements can replicate and insert themselves into new genomic locations. This feature contributes significantly to the evolution of genomes but can also result in DNA breaks and illegitimate recombination, and therefore poses a significant threat to genomic integrity (Belancio et al., 2008). Excessive damage to the germline genome results in sterility. Thus, the piRNA pathway operates in the germline to control the activity of transposable elements.
The PIWI-piRNA pathway plays a role in brain development, and its regulation has emerged as a key factor in the development of various neurological disorders. In rodents, PIWIL1 (MIWI) is expressed in multiple brain tissues, including the hippocampus and cortex, and controls dendritic spine development and morphogenesis (Lee et al., 2011a; Zhao et al., 2015). In addition, PIWIL1 (MIWI) also functions in promoting neuronal polarization and radial migration during neurogenesis (Zhao et al., 2015). In humans, active transposition occurs during neurogenesis, which provides genomic diversity between neurons (Bodea et al., 2018; Erwin et al., 2014). Transposition-driven genomic heterogeneity is also observed in the brains of
In fact,
Growing evidence suggests that the dysregulation of the piRNA pathways results in genomic instability of neurons leading to the development of various neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and tauopathies. Abnormal expression of PIWI has been linked to the pathogenesis of ALS which primarily affects motor neurons. Mutations in RNA-binding proteins, including FUS and TDP-43, have been identified as causative events in ALS (Lagier-Tourenne and Cleveland, 2009; Zhao et al., 2018). In a
Tauopathies refer to neurodegenerative diseases linked with the pathological aggregation of the Tau protein in neurofibrillary tangles in the brain. One of the potential pathological mechanisms of tauopathy is related to PIWI/piRNA regulation (Sun et al., 2018). It has been demonstrated that pathogenic Tau aggregation-induced decondensation of heterochromatin and reduction in PIWI and piRNAs activity results in transposable element dysregulation, causing neuronal cell death in these neurogenerative tauopathies (Frost et al., 2014). In addition, numerous piRNAs were found to be upregulated in human brain samples from Alzheimer’s disease patients and many of the predicted mRNA targets of such piRNAs were significantly downregulated (Qiu et al., 2017; Roy et al., 2017). This makes piRNA regulation a potentially interesting area for the development of novel therapeutic strategies for the treatment of neurodegenerative diseases.
Mounting evidence challenges the notion that PIWI proteins and piRNAs function solely to regulate the activity of transposable elements in the germline. This pathway has now been implicated in the regulation of the expression of endogenous genes in various somatic cells, including neurons. The PIWI-piRNA pathway has been shown to be involved in various neuronal events, including brain development, genomic heterogeneity, neuronal response following injury, behavior, memory formation, and TEI of acquired traits. Dysregulation of the PIWI-piRNA pathway has been implicated in the pathology of various neurological disorders, including neurodevelopmental and neurodegenerative diseases. In many cases, the comprehensive molecular mechanisms underlying activity and regulation of the neuronal piRNA pathway remain largely unknown. Future research will need to evaluate regulatory targets of the piRNA pathway in order to understand its contribution to neuronal gene regulation. Although manipulation or analysis of numerous piRNA sequences remains a technological challenge, rapidly growing genome editing and genome-wide technologies are likely to contribute to our future understanding of the neuronal piRNA pathway. We are just beginning to untangle the influence of this regulatory pathway in the neurons. Understanding the precise mechanisms employed by this pathway should help develop specific piRNAs based therapeutic strategies that could be used in the treatment or diagnosis of various neurological disorders.
This work was supported by the Hallym University research funds (HRF-201809–014).
Mol. Cells 2019; 42(12): 828-835
Published online December 31, 2019 https://doi.org/10.14348/molcells.2019.0241
Copyright © The Korean Society for Molecular and Cellular Biology.
Kyung Won Kim*
Convergence Program of Material Science for Medicine and Pharmaceutics, Department of Life Science, Multidisciplinary Genome Institute, Hallym University, Chuncheon 24252, Korea
Correspondence to:kwkim@hallym.ac.kr
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.
PIWI Argonaute proteins and Piwi-interacting RNAs (piRNAs) are expressed in all animal species and play a critical role in cellular defense by inhibiting the activation of transposable elements in the germline. Recently, new evidence suggests that PIWI proteins and piRNAs also play important roles in various somatic tissues, including neurons. This review summarizes the neuronal functions of the PIWI-piRNA pathway in multiple animal species, including their involvement in axon regeneration, behavior, memory formation, and transgenerational epigenetic inheritance of adaptive memory. This review also discusses the consequences of dysregulation of neuronal PIWI-piRNA pathways in certain neurological disorders, including neurodevelopmental and neurodegenerative diseases. A full understanding of neuronal PIWI-piRNA pathways will ultimately provide novel insights into small RNA biology and could potentially provide precise targets for therapeutic applications.
Keywords: neurological disorders, non-coding RNA, posttranscriptional gene silencing, small RNA, transposable elements
PIWI-interacting RNAs (piRNAs) are small non-coding regulatory RNAs and fall into the same biological category as microRNAs (miRNAs) and small interfering RNAs (siRNAs) (Aravin et al., 2006; Girard et al., 2006). piRNAs form a complex with the PIWI protein and can be found in both vertebrates and invertebrates. piRNAs are distinct from miRNAs in several features, the first is size (piRNAs are generally 24 to 32 nucleotides in length rather than 21 nucleotides), second a lack of sequence conservation, and third independence from Dicer for biogenesis (Vagin et al., 2006; Weick and Miska, 2014). piRNAs often show a bias for a 5′ uridine (Brennecke et al., 2007; Ruby et al., 2006; Stein et al., 2019) and have 2′-O-methylation at the 3′-end (Horwich et al., 2007; Kirino and Mourelatos, 2007; Ohara et al., 2007; Peng et al., 2018; Saito et al., 2007; Tang et al., 2016) (Fig. 1). piRNA is the most diverse class of regulatory RNAs in general. According to piRBase, the number of unique piRNA sequences in the mouse is over 68 million; in
PIWI proteins belong to the Argonaute/Piwi family (Carmell et al., 2002). Like all Argonaute proteins, PIWI proteins contain two RNA-binding domains: the N-terminal PAZ domain and the C-terminal Piwi domain (Cerutti et al., 2000) (Fig. 2A). The Piwi domain has endonuclease activity that allows it to cleave RNA. The PIWI protein was initially described in
The PIWI-piRNA pathway relies on the specificity provided by the piRNA sequence which recognizes its RNA targets using base-pairing complementarity (Gou et al., 2014; Rouget et al., 2010; Saito et al., 2007; Shen et al., 2018; Zhang et al., 2018), while the PIWI protein functions as the effector (Tolia and Joshua-Tor, 2007). PIWI-piRNA complexes silence their target genes at both the transcriptional level and at the posttranscriptional level (Di Giacomo et al., 2013; Toth et al., 2016; Weick and Miska, 2014) (Fig. 1). Gene silencing at the transcriptional level often occurs through the recruitment of repressive chromatin modifications to genomic target loci (Ashe et al., 2012; Le Thomas et al., 2013; Shirayama et al., 2012; Sienski et al., 2012) and
Given that one of the major roles of the piRNA pathway is the inactivation of transposable elements, impairment of this pathway can lead to overexpression of transposable elements, which may result in increased genome stability and thus germ cell defects and sterility. However, many animals produce piRNAs that do not target transposon sequences. For example, the vast majority of piRNAs produced in
PIWI proteins and piRNAs have been identified in various somatic tissues including neural cells, although it should be noted that their expression levels are significantly lower in these tissues than in the germline. A number of studies have detected the expression of piRNAs in the mammalian brain (Dharap et al., 2011; Ghosheh et al., 2016; Lee et al., 2011a; Nandi et al., 2016; Perera et al., 2019; Phay et al., 2018). In mouse brain tissues researchers have identified approximately 30,000 neuronal piRNAs, and interestingly, these neuronal piRNAs are most like PIWIL2 (MIWI) associated piRNAs found in mouse testes (Ghosheh et al., 2016). These somatic piRNAs are shorter in length and tissue-specific, with increased occurrence of unique piRNAs in the hippocampus when compared to the germline (Perera et al., 2019). Hippocampal tissues showed the highest expression of piRNAs of any of the somatic tissues tested, followed by the brain cortex, kidney, and liver (Perera et al., 2019). These findings suggest that the role of neuronal piRNAs might be associated with neurogenesis and learning and memory.
Like other organisms,
Importantly, this inhibitory role in axon regeneration seems to be evolutionarily conserved as a reduction in a PIWI-like protein in cultured adult rat sensory neurons increases axonal regrowth after injury (Phay et al., 2018). In this study, PIWIL1 (MIWI) was detected in rat nervous tissue lysates, and its knockdown enhanced axon regrowth in cultured peripheral neurons after axonal injury. In addition, the authors also detected several neuronal piRNAs in rat sciatic nerve axoplasm and found that many of them are differentially expressed after nerve injury (e.g., piR-1199) (Phay et al., 2018). Another independent study in adult rat brains showed that numerous piRNAs are differentially expressed following transient focal ischemia in the rat cerebral cortex (Dharap et al., 2011).
Furthermore, PIWIL1 (MIWI) is expressed in the mouse Schwann cell and the expression was dramatically reduced following sciatic nerve injury (Sohn et al., 2019). Additionally, thousands of piRNAs were differentially expressed following nerve injury in this model, and one piRNA (piR 009614) even enhanced the migration of Schwann cells.
Together, these nematode and rodent studies suggest that the piRNA pathway may contribute to neuron or Schwann cell responses during peripheral nerve injury. Further studies should be done to determine the exact mechanisms behind PIWI and piRNA mediated axon regeneration and degeneration as well as to elucidate the specific piRNAs and their targets which regulate these neuronal responses after nerve injury.
Another likely role for PIWI and piRNAs in the neuron has been described in
In
Another recent study selectively disrupted PIWI proteins by simultaneous knockdown of two
Transgenerational epigenetic inheritance (TEI) refers to the phenomenon whereby epigenetic information is preserved in multiple generations even when the initiating environment or genetic event is no longer present (Boskovic and Rando, 2018). Environmental challenges, including high temperature (Casier et al., 2019b), starvation (Rechavi et al., 2014), and osmotic stress (Burton et al., 2017), can produce responses that are maintained across generations. In addition, researchers have shown that acquired memory events like traumatic stress (Gapp et al., 2014) and conditioned fear responses (Dias and Ressler, 2014) can also be inherited for up to two generations in mice.
Although the molecular and cellular mechanisms underlying TEI are largely unknown, several mechanisms have been identified as mediators of epigenetic inheritance, including DNA methylation, histone modification, and small RNAs (i.e., siRNAs and piRNAs) (Boskovic and Rando, 2018; Casier et al., 2019a). piRNAs have been shown to affect the epigenetic inheritance via the induction of paramutations in the heritable RNA interference (RNAi) pathway (Ashe et al., 2012; de Vanssay et al., 2012; Houri-Ze’evi et al., 2016; Sapetschnig et al., 2015; Shirayama et al., 2012). In the germline of
Strikingly,
Another groundbreaking discovery by Posner et al. (2019) provided insights into the small RNA-based mechanism of how the nervous system communicates with the germline to affect animal behavior transgenerationally. The authors first identified neuronal small RNAs and focused their research on the endo-siRNAs produced in an RDE-4 (
Transposable elements can replicate and insert themselves into new genomic locations. This feature contributes significantly to the evolution of genomes but can also result in DNA breaks and illegitimate recombination, and therefore poses a significant threat to genomic integrity (Belancio et al., 2008). Excessive damage to the germline genome results in sterility. Thus, the piRNA pathway operates in the germline to control the activity of transposable elements.
The PIWI-piRNA pathway plays a role in brain development, and its regulation has emerged as a key factor in the development of various neurological disorders. In rodents, PIWIL1 (MIWI) is expressed in multiple brain tissues, including the hippocampus and cortex, and controls dendritic spine development and morphogenesis (Lee et al., 2011a; Zhao et al., 2015). In addition, PIWIL1 (MIWI) also functions in promoting neuronal polarization and radial migration during neurogenesis (Zhao et al., 2015). In humans, active transposition occurs during neurogenesis, which provides genomic diversity between neurons (Bodea et al., 2018; Erwin et al., 2014). Transposition-driven genomic heterogeneity is also observed in the brains of
In fact,
Growing evidence suggests that the dysregulation of the piRNA pathways results in genomic instability of neurons leading to the development of various neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and tauopathies. Abnormal expression of PIWI has been linked to the pathogenesis of ALS which primarily affects motor neurons. Mutations in RNA-binding proteins, including FUS and TDP-43, have been identified as causative events in ALS (Lagier-Tourenne and Cleveland, 2009; Zhao et al., 2018). In a
Tauopathies refer to neurodegenerative diseases linked with the pathological aggregation of the Tau protein in neurofibrillary tangles in the brain. One of the potential pathological mechanisms of tauopathy is related to PIWI/piRNA regulation (Sun et al., 2018). It has been demonstrated that pathogenic Tau aggregation-induced decondensation of heterochromatin and reduction in PIWI and piRNAs activity results in transposable element dysregulation, causing neuronal cell death in these neurogenerative tauopathies (Frost et al., 2014). In addition, numerous piRNAs were found to be upregulated in human brain samples from Alzheimer’s disease patients and many of the predicted mRNA targets of such piRNAs were significantly downregulated (Qiu et al., 2017; Roy et al., 2017). This makes piRNA regulation a potentially interesting area for the development of novel therapeutic strategies for the treatment of neurodegenerative diseases.
Mounting evidence challenges the notion that PIWI proteins and piRNAs function solely to regulate the activity of transposable elements in the germline. This pathway has now been implicated in the regulation of the expression of endogenous genes in various somatic cells, including neurons. The PIWI-piRNA pathway has been shown to be involved in various neuronal events, including brain development, genomic heterogeneity, neuronal response following injury, behavior, memory formation, and TEI of acquired traits. Dysregulation of the PIWI-piRNA pathway has been implicated in the pathology of various neurological disorders, including neurodevelopmental and neurodegenerative diseases. In many cases, the comprehensive molecular mechanisms underlying activity and regulation of the neuronal piRNA pathway remain largely unknown. Future research will need to evaluate regulatory targets of the piRNA pathway in order to understand its contribution to neuronal gene regulation. Although manipulation or analysis of numerous piRNA sequences remains a technological challenge, rapidly growing genome editing and genome-wide technologies are likely to contribute to our future understanding of the neuronal piRNA pathway. We are just beginning to untangle the influence of this regulatory pathway in the neurons. Understanding the precise mechanisms employed by this pathway should help develop specific piRNAs based therapeutic strategies that could be used in the treatment or diagnosis of various neurological disorders.
This work was supported by the Hallym University research funds (HRF-201809–014).
Sieun S. Kim and Seung-Jae V. Lee
Mol. Cells 2019; 42(5): 379-385 https://doi.org/10.14348/molcells.2019.0077Ju-Hyun Lee and Woong Sun
Mol. Cells 2022; 45(2): 53-64 https://doi.org/10.14348/molcells.2022.2019Hee-Eun Lee, Sang-Je Park, Jae-Won Huh, Hiroo Imai, and Heui-Soo Kim
Mol. Cells 2020; 43(7): 607-618 https://doi.org/10.14348/molcells.2020.0058